🇺🇸 FDA
Patent

US 7378552

Monoamine re-uptake inhibitors and methods relating thereto

granted A61PA61P25/00

Quick answer

US patent 7378552 (Monoamine re-uptake inhibitors and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P25/00